News

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...
Taiwan News2h
European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation
Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...
CNET on MSN14h
CNET Daily Tariff Price Impact Tracker: I'm Watching 11 Key Products for Inflation
A new report found inflation on the rise in June, renewing concerns that inflation is roaring back thanks to Donald Trump's ...
The Manila Times14h
Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the non-voting equity ...